The luteinizing hormone receptor: Insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells

Molecular and Cellular Endocrinology

Volumn 329, Issue 1-2, 2010, Pages 47-55

  Puett, David ^a   Angelova, Krassimira ^a   da Costa, Marcelo Rocha ^a   Warrenfeltz, Susanne W ^a   Fanelli, Francesca ^b  

^a University of Georgia ^*  (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Gonadotropin; Human chorionic gonadotropin; LH receptor; Luteinizing hormone; Ovarian cancer; SKOV 3 cells

Indexed keywords

LUTEINIZING HORMONE RECEPTOR;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL PROLIFERATION; DEGLYCOSYLATION; DIMERIZATION; GENE ACTIVATION; GENE EXPRESSION; GLYCOSYLATION; HUMAN; IMMUNOBLOTTING; OVARY CANCER; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSGENE; UPREGULATION;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HORMONES; HUMANS; MALE; OVARIAN NEOPLASMS; RECEPTORS, LH;

EID: 77957104740     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.04.025     Document Type: Review

References (78)

1. Angelova K., Fanelli F., Puett D. A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J. Biol. Chem. 2002, 277:32202-32213.
2. Angelova K., Fanelli F., Puett D. Contributions of intracellular loops 2 and 3 of the lutropin receptor in Gs coupling. Mol. Endocrinol. 2008, 22:126-138.
3. Ascoli M., Puett D. The gonadotropin hormones and their receptors. Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management 2009, 35-55. Saunders/Elsevier, Philadelphia. sixth ed. J.F. Strauss, R. R. Barbieri (Eds.).
4. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 2002, 23:141-174.
5. Ballesteros J.A., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relationships in G protein-coupled receptors. Methods Neurosci. 1995, 25:366-428.
6. Bhowmick N., Huang, Puett D., Isaacs N.W., Lapthorn A.J. Determinants of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol. Endocrinol. 1996, 10:1147-1159.
7. Bhowmick N., Narayan P., Puett D. Identification of ionizable residues on the extracellular domain of the lutropin receptorinvolved in ligand binding. Endocrinology 1999, 140:4558-4563.
8. Bogerd J. Ligand-selective determinants in gonadotropin receptors. Mol. Cell. Endocrinol. 2007, 260-262:144-152.
9. Bruysters M.W.P., Verhoef-Post M., Themmen A.P.N. Asp(330) and Tyr(331) in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation. J. Biol. Chem. 2008, 283:25821-25828.
10. Caltabiano G., Campillo M., De Leener A., Smits G., Vassart G., Costagliola S., Pardo L. The specificity of binding of glycoprotein hormones to their receptors. Cell. Mol. Life Sci. 2008, 1-9.
11. Choi J.-H., Choi K.-C., Auersperg N., Leung P.C.K. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Cancer Res. 2006, 66:3912-3920.
12. Choi J.-H., Wong A.S.T., Huang H.-F., Leung P.C.K. Gonadotropins and ovarian cancer. Endocr. Rev. 2007, 28:440-461.
13. Coonce M.M., Rabideau A.C., McGee S., Smith K., Narayan P. Impact of a constitutively active luteinizing hormone receptor on testicular gene expression and postnatal Leydig cell development. Mol. Cell. Endocrinol. 2009, 298:33-41.
14. De Beer T., Van Zuylen C.W.E.M., Leeflang B.R., Had K., Boelens R., Kaptein R., Kamerling J.P., Vliegenthart J.F.G. NMR studies of the free alpha subunit of human chorionic gonadotropin: structural influences of N-glycosylation and the beta subunit on the conformation of the alpha subunit. Eur. J. Biochem. 1996, 241:229-242.
15. Erbel P.J.A., Karimi-Nejad Y., De Beer T., Boelens R., Kamerling J.P., Vliegenthart J.F.G. Solution structure of the alpha-subunit of human chorionic gonadotropin. Eur. J. Biochem. 1999, 260:490-498.
16. Fan Q.R., Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its recepto. Nature 2005, 433:269-277.
17. Fan Q.R., Hendrickson W.A. Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol. Cell. Endocrinol. 2007, 260-262:73-82.
18. Fanelli F. Dimerization of the lutropin receptor: insights from computational modeling. Mol. Cell. Endocrinol. 2007, 260-262:59-64.
19. Fanelli F., De Benedetti P.G., Raimondi R., Seeber M. Computational modeling of intramolecular and intermolecular communication in GPCRs. Curr. Prot. Pept. Sci. 2009, 10:173-185.
20. Feng X.Y., Muller T., Mizrachi D., Fanelli F., Segaloff D.L. An intracellular loop (IC2) residue confers different basal constitutive activities to the human lutropin receptor and human thyrotropin receptor through structural communication between IL2 and helix 6, via helix 3. Endocrinology 2008, 149:1705-1717.
21. Fiser A., Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol. 2003, 374:461-491.
22. Fox K.M., Dias J.A., Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol. Endocrinol. 2001, 15:378-389.
23. Fralish G.B., Dattilo B., Puett D. Structural analysis of yoked chorionic gonadotropin-luteinizing hormone receptor ectodomain complexes by circular dichroic spectroscopy. Mol. Endocrinol. 2003, 17:1192-1202.
24. Fregien N.L., White L.A., Bunge M.B., Wood P.M. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA. Glia 2005, 49:24-35.
25. Gabb H.A., Jackson R.M., Sternberg M.J. Modelling protein docking using shape complementarity, electrostatics and biochemical information. J. Mol. Biol. 1997, 272:106-120.
26. Guan R., Feng X., Wu X., Zhang M., Zhang X., Hebert T.E., Segaloff D.L. Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J. Biol. Chem. 2009, 284:7483-7494.
27. He X.L., Bazan J.F., McDermott G., Park J.B., Wang K., Tessier-Lavigne M., He Z., Garcia K.C. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 2003, 38:177-185.
28. Holbro T., Civenni G., Hynes N.E. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 2003, 284:99-110.
29. Hsieh S.S., Malerczyk C., Aigner A., Czubayko F. ErbB-2 expression is rate limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation. Int. J. Cancer 2000, 86:644-651.
30. Huizinga E.G., Tsuji S., Romijn R.A.P., Schiphorst M.E., de Groot P.G., Sixma J.J., Gros P. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 2002, 297:1176-1179.
31. Jeoung M.K., Lee C.W., Ji I., Ji T.H. Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol. Cell. Endocrinol. 2007, 260-262:137-143.
32. Ji I., Lee C., Song Y., Conn P.M., Ji T.H. Cis- and trans-activation of hormone receptors: the LH receptor. Mol. Endocrinol. 2002, 16:1299-1308.
33. Kleinau G., Krause G. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr. Rev. 2009, 30:133-151.
34. Kleinau G., Brehm M., Wiedemann U., Labudde D., Leser U., Krause G. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol. Endocrinol. 2007, 21:574-580.
35. Lapthorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J., Morgan F.J., Isaacs N.W. Crystal structure of human chorionic gonadotropin. Nature 1994, 369:455-461.
36. Lee C., Ji I., Ryu K., Song Y., Conn P.M., Ji T.H. Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J. Biol. Chem. 2002, 277:15795-15800.
37. Leung P.C.K., Choi J.-H. Endocrine signaling in ovarian surface epithelium and cancer. Hum. Reprod. Update 2007, 13:143-162.
38. Mandai M., Konishi I., Kuroda H., Fujii S. LH/hCG action and development of ovarian cancer-a short review on biological and clinical/epidemiological aspects. Mol. Cell. Endocrinol. 2007, 269:61-64.
39. Meehan T.P., Narayan P. Constitutively active luteinizing hormone receptors: consequences of in vivo expression. Mol. Cell. Endocrinol. 2007, 260-262:294-300.
40. Meehan T.P., Harmon B.G., Overcast M.E., Yu K.K., Camper S.A., Puett D., Narayan P. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. J. Mol. Endocrinol. 2005, 34:489-503.
41. Moyle W.R., Campbell R.K., Myers R.V., Bernard M.P., Han Y., Wang X. Co-evolution of ligand-receptor pairs. Nature 1994, 368:251-255.
42. Mustafi D., Palczewski K. Topology of Class A G protein-coupled receptors: insights gained from crystal structures of rhodopsins, adrenergic, and adenosine recptors. Mol. Pharmacol. 2009, 75:1-12.
43. Narayan P., Wu C., Puett D. Genetic engineering of single chain gonadotropins and hormone-receptor fusion proteins. Methods 2000, 21:59-66.
44. Narayan P., Gray J., Puett D. Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. Mol. Endocrinol. 2002, 16:2733-2745.
45. Parrott J.A., Doraiswamy V., Kim G., Mosher R., Skinner M.K. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol. Cell. Endocrinol. 2001, 172:213-222.
46. Puett D., Wu C., Narayan P. The tie that binds: design of biologically active single chain chorionic gonadotropins and and a gonadotropin-receptor complex using protein engineering. Biol. Reprod. 1998, 58:1337-1342.
47. Puett D., Li Y., Angelova K., DeMars G., Meehan T.P., Fanelli F., Narayan P. Structure-function relationships of the luteinizing hormone receptor. Ann. N. Y. Acad. Sci. 2005, 1061:41-54.
48. Puett D., Li Y., DeMars G., Angelova K., Fanelli F. A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein. Mol. Cell. Endocrinol. 2007, 260-262:126-136.
49. Rao C.H.V., Li X., Manna S.K., Lei Z.M., Aggarwal B.B. Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-κB and AP-1 activation. J. Biol. Chem. 2004, 279:25503-25510.
50. Rivero-Muller A., Chou Y.-Y., Ji I., Lajic S., Hanyaloglu A.C., Jonas K., Rahman N., Ji T.H., Huhtaniemi I. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2319-2324.
51. Roess D.A., Horvat R.D., Munnelly H., Barisas B.G. Luteinizing hormone receptors are self-associated in the plasma membrane. Endocrinology 2000, 141:4518-4523.
52. Rosenbaum D.M., Rasmussen S.G.F., Kobilka B.K. The structure and function of G protein-coupled receptors. Nature 2009, 459:356-363.
53. Sali A., Blundell T.L. Comparative protein modeling by satisfaction of spatial restraints. J. Mol. Biol. 2003, 234:779-815.
54. Sanders J., Chirgadze D.Y., Sanders P., Baker S., Sullivan A., Bhardwaja A., Bolton J., Reeve M., Nakatake N., Evans M., Richards T., Powell M., Nunez Miguel R., Blundell T.L., Furmaniak J., Rees Smith B. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 2007, 17:395-410.
55. Schubert R.L., Puett D. Single-chain human chorionic gonadotropin analogs containing the determinant loop of the β-subunit linked to the α-subunit. J. Mol. Endocrinol. 2003, 31:157-168.
56. Schubert R.L., Narayan P., Puett D. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone. Endocrinology 2003, 144:129-137.
57. Segaloff D.L. Diseases associated with mutations of the human lutropin receptor. Progress in Molecular Biology and Translational Science: G Protein-Coupled Receptors in Health and Disease, Part B 2009, 97-114. Elsevier, London. Y.-X. Tao (Ed.).
58. Smits G., Campillo M., Govaerts C., Janssens V., Richter C., Vassart G., Pardo L., Costagliola S. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J. 2003, 22:2692-2703.
59. Song Y.S., Ji I., Beauchamp J., Isaacs N.W., Ji T.H. Hormone interactions to Leu-rich repeats in the gonadotropin receptors (I). J. Biol. Chem. 2001, 276:3426-3435.
60. Song Y.S., Ji I., Beauchamp J., Isaacs N.W., Ji T.H. Hormone interactions to Leu-rich repeats in the gonadotropin receptors (II). J. Biol. Chem. 2001, 276:3436-3442.
61. Tao Y.-X., Johnson N.B., Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J. Biol. Chem. 2004, 279:5904-5914.
62. Tegoni M., Spinelli S., Verhoeyen, Davis P., Cambillau C. Crystal structure of a ternary complex between human chorionic gonadotropin (hCG) and two Fv fragments specific for the alpha and beta-subunits. J. Mol. Biol. 1999, 289:1375-1385.
63. Themmen A.P.N. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 2005, 130:263-274.
64. Tourgeman D.E., Lu J.J., Boostanfar R., Amezcua C., Felix J.C., Paulson R.J. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil. Steril. 2002, 78:1096-1099.
65. Urizar E., Montanelli L., Loy T., Bonomi M., Swillens S., Gales C., Bouvier M., Smits G., Vassart G., Costagliola S. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J. 2005, 24:1954-1964.
66. Van Durme J., Horn F., Costagliola S., Vriend G., Vassart G. GRIS: glycoprotein-hormone receptor information system. Mol. Endocrinol. 2006, 20:2247-2255.
67. Vassart G., Pardo L., Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem. Sci. 2004, 29:119-126.
68. Vischer H.F., Granneman J.C.M., Bogerd J. Opposite contribution of two ligand-selective determinants in the N-terminal hormone-binding exodomainof human gonadotropin receptors. Mol. Endocrinol. 2003, 17:1972-1981.
69. Vischer H.F., Granneman J.C.M., Noordam M.J., Mosselman S., Bogerd J. Ligand selectivity of gonadotropin receptors. Role of the beta-strands of extracellular leucine-rich repeats 3 and 6 of the human luteinizing hormone receptor. J. Biol. Chem. 2003, 278:15505-15513.
70. Vischer H.F., Granneman J.C.M., Bogerd J. Identification of follicle-stimulating hormone-selective β-strands in the N-terminal hormone-binding exodomain of human gonadotropin receptors. Mol. Endocrinol. 2006, 20:1880-1893.
71. Warrenfeltz S.W., Lott S.A., Palmer T.M., Gray J.C., Puett D. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells. Mol. Cancer Res. 2008, 6:1775-1785.
72. Wu C., Narayan P., Puett D. Protein engineering of a novel constitutively active hormone-receptor complex. J. Biol. Chem. 1996, 271:31638-31642.
73. Wu H., Lustbader J.W., Liu Y., Canfield R.E., Hendrickson W.A. Structure of human chorionic gonadotropin at 2.6Å resolution from MAD analysis of the selenomethionylprotein. Structure 1994, 2:545-558.
74. Yu D., Wolf J.K., Scanlon M., Price J.E., Hung M.C. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res. 1993, 53:891-898.
75. Zeng H., Phang T., Song Y.S., Ji I., Ji T.H. The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation. J. Biol. Chem. 2001, 276:3451-3458.
76. Zhang M.L., Tao Y.X., Ryan G.L., Feng X.Y., Fanelli F., Segaloff D.L. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J. Biol. Chem. 2007, 282:25527-25539.
77. Zhang M., Feng X., Guan R., Hebert T.E., Segaloff D.L. A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerzation. Cell Signal. 2009, 21:1663-1671.
78. Zheng W., Lu J.J., Luo F., Zheng Y., Feng Y.-J., Felix J.C., Lauchlan S.C., Pike M.C. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol. Oncol. 2000, 76:80-88.